RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 133 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $2,421,000 | -27.0% | 913,621 | 0.0% | 0.73% | -30.9% |
| Q3 2021 | $3,316,000 | -7.9% | 913,621 | +10.1% | 1.06% | +18.1% |
| Q2 2021 | $3,601,000 | -12.9% | 829,721 | -48.4% | 0.90% | -19.9% |
| Q1 2019 | $4,136,000 | -17.5% | 1,609,265 | -26.2% | 1.12% | -38.9% |
| Q4 2018 | $5,015,000 | -15.3% | 2,180,546 | +18.3% | 1.83% | -10.0% |
| Q3 2018 | $5,918,000 | +49.5% | 1,843,501 | +31.8% | 2.03% | -7.2% |
| Q2 2018 | $3,958,000 | +15.3% | 1,398,618 | +58.0% | 2.19% | +13.0% |
| Q4 2017 | $3,434,000 | -13.5% | 885,055 | -43.4% | 1.94% | -6.0% |
| Q3 2017 | $3,971,000 | +8.1% | 1,563,307 | +16.2% | 2.06% | +18.0% |
| Q2 2017 | $3,674,000 | -41.2% | 1,345,723 | -28.7% | 1.75% | -50.1% |
| Q1 2017 | $6,250,000 | +107.8% | 1,888,181 | +49.5% | 3.50% | +99.3% |
| Q4 2016 | $3,007,000 | -19.7% | 1,263,390 | +23.8% | 1.75% | -32.1% |
| Q3 2016 | $3,746,000 | +26.0% | 1,020,719 | -23.5% | 2.58% | +70.0% |
| Q2 2016 | $2,974,000 | -11.6% | 1,333,696 | -17.5% | 1.52% | +23.4% |
| Q1 2016 | $3,363,000 | – | 1,616,896 | – | 1.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 9,105,691 | $30,140,000 | 5.99% |
| Sio Capital Management, LLC | 1,888,181 | $6,250,000 | 3.50% |
| DAFNA Capital Management LLC | 473,478 | $1,567,000 | 1.32% |
| Cormorant Asset Management, LP | 2,000,000 | $6,620,000 | 0.96% |
| Ghost Tree Capital, LLC | 1,100,000 | $3,641,000 | 0.68% |
| Rhenman & Partners Asset Management AB | 1,282,000 | $4,243,000 | 0.67% |
| Palo Alto Investors LP | 4,254,623 | $14,083,000 | 0.67% |
| NEA Management Company, LLC | 3,243,150 | $10,375,000 | 0.36% |
| Telemetry Investments, L.L.C. | 170,000 | $563,000 | 0.25% |
| NJ State Employees Deferred Compensation Plan | 355,000 | $1,175,000 | 0.22% |